Biotech Company issued a convertible bond on November 1, 2022. The $6,500,000 bond pays annual interest of 7%, each October 31. Each $1,000 bond is convertible into 50 shares of common stock, at the investor's option, on November 1, 2027, up to November 1, 2034, after which each $1,000 bond may be converted into 44.5 shares until bond maturity on October 31, 2038. Market analysts have indicated that, had the bond not been convertible, it would have sold for $4,970,000 (rounded), reflecting a market interest rate of 10% annually. In fact, it was issued for $6,790,000. Please make sure your final answer(s) are accurate to 2 decimal places. a) Record the journal entry for the initial bond issuance assuming that the company will use a method permitted by IFRS to value the debt and equity components. Enter an appropriate description, and enter the date in the format dd/mmm (ie. 15/Jan). b) Verify the $4,970,000 price of the bond by calculating the present value of the bond. c) How much interest expense would have been recorded in the first 12 months if the bond was recorded at $4,970,000? Assume straight-line amortization of bond discount or premium. d) How much interest expense